Express News | Marinus Pharmaceuticals Inc - on Dec 6, Receives Nasdaq Notice for Minimum Bid Price Deficiency

ReutersDec 10 16:43 ET

US$1.86: That's What Analysts Think Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) Is Worth After Its Latest Results

Yahoo FinanceNov 15 05:49 ET

Marinus Pharmaceuticals Price Target Maintained With a $2.00/Share by HC Wainwright & Co.

Dow JonesNov 14 06:57 ET · Ratings

Express News | D. Boral Capital Maintains Buy on Marinus Pharma, Maintains $3 Price Target

BenzingaNov 13 18:04 ET

JMP Securities Maintains Marinus Pharmaceuticals(MRNS.US) With Hold Rating

Moomoo NewsNov 13 11:31 ET · Ratings

Hold Rating on Marinus Pharmaceuticals Amid Strategic Uncertainty and TRUST-TSC Study Setbacks

TipRanksNov 13 11:16 ET